Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-03-28

FDA Approved: ABACAVIR AND LAMIVUDINE — Original Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' generic fixed-dose combination tablet of abacavir and lamivudine. It is indicated for the treatment of HIV-1 infection in co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ABACAVIR AND LAMIVUDINE (abacavir/lamivudine)

Snippet

ORIG AP for ABACAVIR AND LAMIVUDINE (ABACAVIR AND LAMIVUDINE)